Metabolic Syndrome News and Research

Latest Metabolic Syndrome News and Research

Rimonabant could be safer for treating obesity than previous weight-loss drugs

ECRI, a nonprofit health services research agency, recently published a Health Technology Forecast profile on a novel pharmaceutical agent that is in development for the treatment of obesity.

30 Nov 2004

Metabolic syndrome is a public health time bomb

The metabolic syndrome is a public health time bomb. It may affect as many as 1 in 5 adults in some parts of Europe, greatly increasing the risk of developing heart disease and stroke.

29 Nov 2004

Keeping fit lowers C-Reactive protein in people with metabolic syndrome

In people with signs of metabolic syndrome, including high blood pressure, high triglycerides, high cholesterol, elevated blood glucose and obesity, physical activity appears to reduce a marker for inflammation which has been linked to heart disease

16 Nov 2004

Shp2 protein plays a critical role in obesity

A team of researchers led by The Burnham Institute's Gen-Sheng Feng, Ph.D. has discovered that a protein called Shp2 plays a critical role in obesity.

11 Nov 2004

The risk of developing metabolic syndrome increases the more a person drinks

The risk of developing metabolic syndrome increases the more a person drinks – and beginning a heavy drinking pattern early in life seems to add extra risk, according to a first-of-its-kind study presented at the American Heart Association’s Scientific Sessions 2004.

11 Nov 2004

Metabolic syndrome associated with cognitive decline in elderly persons

Elderly individuals with the metabolic syndrome, a grouping of several common conditions including abdominal obesity, low level of high-density lipoprotein (HDL, the “good cholesterol”), hypertension, and high triglyceride and blood sugar levels, are more likely to experience cognitive impairment than those without this syndrome, according to a study in the November 10 issue of JAMA.

10 Nov 2004

New beta blocker may help diabetic patients with high blood pressure

A medication that is commonly used to control high blood pressure does not raise blood sugar levels in diabetics who also have high blood pressure, according to researchers from Rush University Medical Center.

9 Nov 2004

Stable weight significantly reduces risks of heart disease and development of metabolic syndrome

Gaining 15 pounds or more over several years is the major contributor to progression of risk factors for heart disease and development of metabolic syndrome, while maintaining a stable weight -- even in individuals considered obese – significantly reduces those risks, according to a study led by a Northwestern University researcher.

8 Nov 2004

Discovery of internal molecular clock that governs the metabolism of sugars and fats within the body

Researchers at the University of Pennsylvania School of Medicine have discovered that components of the internal molecular clock of mammals have an important role in governing the metabolism of sugars and fats within the body.

4 Nov 2004

To avoid metabolic syndrome is relatively simple – 30 minutes of physical activity once a week

Metabolic syndrome is a condition that is affecting thousands of Canadians and is putting them at risk of heart disease and stroke, especially those aged 50 and over.

25 Oct 2004

Weight loss surgery reduces components of metabolic syndrome in obese patients

Obese patients who underwent surgical treatment for weight loss had significant reductions in the components of the metabolic syndrome one year after surgery, according to an article in the October issue of The Archives of Surgery.

18 Oct 2004

Location of body fat on older women can indicate the likelihood of heart disease

The location of body fat on older women can indicate the likelihood of heart disease, according to a new study published in The Journal of Clinical Endocrinology & Metabolism.

16 Oct 2004

Lifestyle factors that increase the risk of heart disease in adults begin to take hold in childhood

In one study, Boston researchers found that about two-thirds of 1,960 adolescents studied had at least one risk factor for heart disease, and almost 10 percent had a cluster of factors known as metabolic syndrome.

11 Oct 2004

Interleukin-6 has potential as a therapeutic drug in treating metabolic disorders such as obesity, type 2 diabetes and atherosclerosis

For the most of the past century, researchers have searched for a muscle-contraction-induced factor, which mediates some of the exercise effects in other tissues and organs such as the liver and adipose tissue.

5 Oct 2004

New genomic, proteomic tools yield clues to exercise/diet effects on obesity, metabolic syndrome and diabetes

Applying the latest genomic and proteomic techniques has given researchers new clues for the interaction between exercise and diet, glucose metabolism and improvement in cardiovascular disease (CVD) risk factors.

5 Oct 2004

Patent pending discovery could help type 2 diabetics

Scientists from MitoChroma Research have recently announced a patent-pending discovery that could complement current medical management modalities for Type 2 Diabetes, insulin resistance and the set of related conditions called "Metabolic Syndrome."

4 Oct 2004

Research findings may help stave off full-blown diabetes

A new study by researchers at Joslin Diabetes Center sheds light on the key mechanisms by which new pancreatic beta cells normally form in response to insulin resistance. These findings may some day help researchers devise ways of staving off full-blown diabetes.

18 Sep 2004

Measuring body fat has just got easier and a whole lot more sophisticated

The space capsule-like pod measures and tracks body fat and lean muscle mass using air displacement technology – replacing the tape measure and callipers or water displacement tanks previously used in research.

13 Sep 2004

Ezetrol co-administration with statin therapy lowers LDL cholesterol in diabetics

Results from two new clinical trials show that patients with diabetes and metabolic syndrome who are treated with ezetimibe (EZETROL®) co-administered with a statin experience greater reductions in LDL (“bad”) cholesterol, compared to patients taking a statin alone.

7 Sep 2004

New study confirms benefits of rimonabant in weight loss

Phase III clinical study comparing placebo to rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers, showed that overweight or obese people taking rimonabant 20mg once daily benefited from a significant reduction in their body weight

29 Aug 2004

Metabolic Syndrome News and Research

Latest Metabolic Syndrome News and Research

Rimonabant could be safer for treating obesity than previous weight-loss drugs

Metabolic syndrome is a public health time bomb

Keeping fit lowers C-Reactive protein in people with metabolic syndrome

Shp2 protein plays a critical role in obesity

The risk of developing metabolic syndrome increases the more a person drinks

Metabolic syndrome associated with cognitive decline in elderly persons

New beta blocker may help diabetic patients with high blood pressure

Stable weight significantly reduces risks of heart disease and development of metabolic syndrome

Discovery of internal molecular clock that governs the metabolism of sugars and fats within the body

To avoid metabolic syndrome is relatively simple – 30 minutes of physical activity once a week

Weight loss surgery reduces components of metabolic syndrome in obese patients

Location of body fat on older women can indicate the likelihood of heart disease

Lifestyle factors that increase the risk of heart disease in adults begin to take hold in childhood

Interleukin-6 has potential as a therapeutic drug in treating metabolic disorders such as obesity, type 2 diabetes and atherosclerosis

New genomic, proteomic tools yield clues to exercise/diet effects on obesity, metabolic syndrome and diabetes

Patent pending discovery could help type 2 diabetics

Research findings may help stave off full-blown diabetes

Measuring body fat has just got easier and a whole lot more sophisticated

Ezetrol co-administration with statin therapy lowers LDL cholesterol in diabetics

New study confirms benefits of rimonabant in weight loss

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Metabolic Syndrome News and Research

Latest Metabolic Syndrome News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in